What is Genomic Life?
Founded in 2017 and headquartered in La Jolla, California, Genomic Life operates as a specialized advisor to the life insurance and benefits brokerage sectors. By integrating genomic medicine into traditional insurance frameworks, the company provides a sophisticated bridge between clinical insights and risk management. This positioning allows Genomic Life to address the evolving needs of insurers who are increasingly looking to leverage health data to improve policyholder outcomes and refine underwriting precision. As a key player in the insurtech landscape, the firm is effectively transforming how benefits are structured and delivered in a data-driven economy.
How much funding has Genomic Life raised?
Genomic Life has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Genomic Life
PPP
Public-Private Partnership
What's next for Genomic Life?
Following this major strategic investment, Genomic Life is well-positioned to scale its operations and expand its footprint within the insurance ecosystem. The current late-stage funding context suggests a transition toward broader market penetration and the potential for enhanced product development. Future growth will likely focus on deepening partnerships with major brokerage firms and refining the technological infrastructure required to handle complex genomic datasets at scale. By maintaining its focus on the nexus of health and finance, the company is poised to capitalize on the growing demand for personalized insurance solutions, ensuring long-term sustainability and competitive advantage in a rapidly digitizing industry.
See full Genomic Life company page
